Evidence map›Paper›PMID 32033289›Full record

ArticleMedicina (Kaunas, Lithuania)2020

Rare Breast Carcinoma with Paradoxical Plasma Cell Immunoprofile: A Case Report.

Eugen Sebastian Grădinaru, Mihai-Ciprian Stoicea, Liliana Mocanu, Iulian Antoniac, Daniela Gheorghiță, Alina Gabriela Mihaela Grigore

Abstract readCase Reports
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Magnetic Hydrogels as a Treatment for Oncological Pathologies.Journal of functional biomaterials · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eugen Sebastian GrădinaruIV Surgical Department, University Emergency Hospital, 050098 Bucharest, Romania.
Mihai-Ciprian StoiceaDepartment of Pathology, Regina Maria Central Laboratory, 060044 Bucharest, Romania.
Liliana MocanuDepartment of Pathology, County Emergency Hospital, 900591 Constanța, Romania.
Iulian AntoniacFaculty of Materials Science and Engineering, Politehnica University of Bucharest, 060042 Bucharest, Romania.
Daniela GheorghițăFaculty of Materials Science and Engineering, Politehnica University of Bucharest, 060042 Bucharest, Romania.
Alina Gabriela Mihaela GrigoreDepartment of Pathology, Regina Maria Central Laboratory, 060044 Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma cell features are encountered in a variety of non-plasma cell neoplasias, especially carcinomas of a discohesive type, such as those occurring in the digestive tract and breast. Lobular carcinomas of the breast present themselves in a variety of architectural patterns and many cell morphologies, including plasmacytoid types. A matching plasma cell phenotype is sometimes an associated feature. We report a case of a moderate grade invasive lobular carcinoma with focal plasmacytoid morphology and aberrant expression of plasma cell markers in a patient previously diagnosed with multiple myeloma. Paradoxical plasma cell immunoprofiles can be encountered in many malignancies, causing serious diagnostic problems, even more so with those occurring in discohesive carcinomas in multiple myeloma patients.

Indexed as

Adipose TissueAgedAntibodies, NeoplasmBreast NeoplasmsCarcinoma, LobularFemaleHumansImmunoglobulin kappa-ChainsImmunohistochemistryMultiple MyelomaParaffin EmbeddingPhenotypePlasma CellsRare DiseasesSyndecan-1Antibodies, NeoplasmImmunoglobulin kappa-ChainsSDC1 protein, humanSyndecan-1lobular carcinomamultiple myelomaplasma cell differentiation

Identifiers

PMID32033289
PMCPMC7074448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.